Sashendra Senthi

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.8K citations

Open-label Trial, Radiation Therapy, Medicine +7

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis

Sashendra Senthi, Frank J. Lagerwaard, Cornelis J.A. Haasbeek et al. · The Lancet Oncology · 2012 · 441 citations

Radiation Therapy, Medicine, Cancer Recurrence +8

Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

David A. Palma, Robert Olson, Stephen Harrow et al. · BMC Cancer · 2019 · 250 citations · Full text

High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer

Kitty Huang, Sashendra Senthi, David A. Palma et al. · Radiotherapy and Oncology · 2013 · 142 citations

Adaptive Radiotherapy, Medical Imaging, Radiation Therapy +10